Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Revenue (2016 - 2025)

Historic Revenue for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $79.4 million.

  • Angiodynamics' Revenue rose 904.39% to $79.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was $307.3 million, marking a year-over-year increase of 726.29%. This contributed to the annual value of $292.5 million for FY2025, which is 375.63% down from last year.
  • Latest data reveals that Angiodynamics reported Revenue of $79.4 million as of Q4 2025, which was up 904.39% from $75.7 million recorded in Q3 2025.
  • Over the past 5 years, Angiodynamics' Revenue peaked at $91.1 million during Q2 2023, and registered a low of $67.5 million during Q3 2024.
  • Moreover, its 5-year median value for Revenue was $77.6 million (2021), whereas its average is $77.7 million.
  • As far as peak fluctuations go, Angiodynamics' Revenue skyrocketed by 3173.22% in 2021, and later crashed by 2206.34% in 2024.
  • Quarter analysis of 5 years shows Angiodynamics' Revenue stood at $78.3 million in 2021, then rose by 9.13% to $85.4 million in 2022, then dropped by 7.44% to $79.1 million in 2023, then decreased by 7.88% to $72.8 million in 2024, then grew by 9.04% to $79.4 million in 2025.
  • Its Revenue stands at $79.4 million for Q4 2025, versus $75.7 million for Q3 2025 and $80.2 million for Q2 2025.